ETV4 and melanoma: Immune checkpoint signaling modulates T cell function, and our RNA-seq analysis of SK-MEL-28 cells identified PD-L1 as the predominant immune checkpoint regulated by ETV4 in melanoma, consistent with findings in hepatocellular carcinoma [16].